[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Konya Beyhekim Training and Research Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":389},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,14,0,[8,53,76,103,128,157,185,214,236,266,295,319,347,370],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100630864","usg-guided-shoulder-injections-in-frozen-shoulder-100630864",false,"NCT07493213","USG-Guided Shoulder Injections in Frozen Shoulder","Effectiveness of USG-Guided Shoulder Injections as an Adjunct to a Home Exercise Program in the Conservative Management of Painful Frozen Shoulder and Its Association With Pain Phenotypes","Inclusion Criteria:\n\nAge between 18 and 75 years and willingness to participate in the study\n\nPresence of shoulder pain lasting at least 3 months and a diagnosis of primary frozen shoulder\n\nPain intensity ≥ 4\u002F10 on the Visual Analog Scale (VAS), resistant to medical treatment\u002Fanalgesics\n\nRestriction of ≥30 degrees in at least two planes of shoulder motion (flexion, abduction, or external rotation)\n\n\\-\n\nExclusion Criteria:\n\n* History of shoulder trauma\n\nPresence of neurological conditions such as stroke, brachial plexus injury, Parkinson's disease, or cervical spine pathology with or without radiculopathy\n\nHistory of shoulder surgery, shoulder malignancy or tumor, or prior shoulder manipulation\n\nPresence of shoulder arthritis, rotator cuff tear, other shoulder injuries, or thoracic outlet syndrome\n\nSystemic diseases affecting the shoulder, severe degeneration or trauma (e.g., osteoarthritis, rheumatoid arthritis, labral or articular cartilage injuries), or inflammatory rheumatic diseases\n\nSteroid injection to the affected extremity within the last 3 months, use of oral steroids or NSAIDs, or ongoing surgical\u002Finterventional treatment\n\nPregnancy or lactation\n\nUncontrolled diabetes, heart failure, or uncontrolled systemic diseases (e.g., liver failure, chronic kidney disease, significant endocrine disorders)\n\nCommunication problems or severe psychiatric disorders","ALL","18 Years","75 Years",{"count":20,"type":21},68,"ESTIMATED","INTERVENTIONAL",[24],"NA","Frozen shoulder (adhesive capsulitis) is characterized by pain and a progressive restriction of both active and passive shoulder range of motion, significantly impairing daily activities and quality of life. This study aims to evaluate the effectiveness of USG-guided shoulder injections, when added to a home-based exercise program, in the conservative management of patients with chronic, painful frozen shoulder.\n\nIn this prospective randomized study, patients diagnosed with painful frozen shoulder will be included. In addition to a standardized home-based exercise program, patients will receive either USG-guided suprascapular nerve block alone or a combination of suprascapular nerve block and subacromial injection. The effects of these approaches on clinical outcomes will be assessed over a 20-week follow-up period.\n\nPrimary outcome measures include pain intensity assessed by the Visual Analog Scale (VAS), functional status evaluated by the Shoulder Pain and Disability Index (SPADI), and shoulder range of motion. Secondary outcomes include depression level (Beck Depression Inventory), sleep quality, pain phenotype (nociplastic, neuropathic, or nociceptive), hand grip strength, ultrasonographic findings ( (coracohumeral ligament thickness, subacromial bursa thickness) , and patient satisfaction (subjective impression of improvement).\n\nThe results of this study are expected to provide evidence on the comparative effectiveness and additional benefits of different shoulder injection approaches when combined with home-based exercise therapy in patients with chronic frozen shoulder.",[27,28,29,30,31],"Frozen Shoulder","Adhesive Capsulitis","Shoulder Pain","Nociplastic Pain","Neuropathic Pain",[27,28,33,34,29,35,36,37,38,39],"Shoulder Injection","Home Exercise Program","Range of Motion","SPADI","Ultrasound-Guided Injection","pain phenotypes","exercises","RECRUITING","2026-05-11",{"date":43,"type":44},"2026-05-14","ACTUAL",{"date":46,"type":44},"2026-04-01",{"date":48,"type":21},"2027-06-30",{"name":50,"class":51},"Konya Beyhekim Training and Research Hospital","OTHER_GOV",1,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":4,"eligibilityCriteria":59,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":60,"targetDuration":4,"studyType":22,"phases":62,"briefSummary":63,"conditions":64,"keywords":66,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":71,"startDateStruct":72,"completionDateStruct":73,"leadSponsor":75,"locationsCount":52},"100630865","efficacy-of-chemically-distinct-nonsteroidal-anti-inflammatory-drugs-nsaids-and-pain-phenotypes-in-adhesive-capsulitis-100630865","NCT07493226","Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis","Comparative Efficacy of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) With Distinct Chemical Structures in Shoulder Adhesive Capsulitis and the Role of Pain Phenotypes","Inclusion Criteria:\n\n1. Being between 18-75 years of age\n2. Having shoulder pain that has lasted for at least one month and being diagnosed with primary frozen shoulder\n3. Having a VAS pain level ≥ 4\u002F10\n4. Having ≥30 degrees of range of motion restriction in at least two planes (flexion, abduction, or external rotation)\n5. Not having any exclusion criteria and agreeing to participate in the study voluntarily\n\nExclusion Criteria:\n\n1. Patients with a history of shoulder trauma, those with musculoskeletal disorders characterized by pain and loss of function in the affected extremity (such as lateral epicondylitis, flexor tendon injury, de Quervein's tenosynovitis)\n2. Presence of neurological involvement such as stroke, brachial plexus injury, Parkinson's disease, and cervical spine injury with or without radiculopathy\n3. History of shoulder surgery, malignancy or tumor in the shoulder, those who have undergone shoulder manipulation\n4. Presence of shoulder arthritis, rotator cuff tear or other shoulder injuries, thoracic outlet syndrome\n5. Systemic disease affecting the shoulder region, severe degeneration or trauma (e.g., osteoarthritis, rheumatoid arthritis, history of labrum or articular cartilage injuries), inflammatory rheumatic diseases\n6. Those who have received steroid injections into the affected extremity within the last 3 months, those using oral steroids or NSAIDs, those receiving any surgical or interventional treatment, or Planned individuals:\n7. Those who are pregnant or lactating\n8. Those with uncontrolled diabetes, heart failure, uncontrolled systemic disease (liver disease, chronic kidney failure, significant endocrine disorders, etc.)\n9. Those with communication problems, severe psychiatric disorders\n10. Those allergic to NSAIDs or with any contraindications\n11. Those with bleeding, coagulation disorders, stomach ulcers, or symptomatic gastritis",{"count":61,"type":21},120,[24],"Patients aged 18-75 years who present to a tertiary rehabilitation hospital with shoulder pain and restricted range of motion, and who consent to participate, will be included in the study. Eligibility will be determined based on predefined inclusion and exclusion criteria.\n\nEligible patients will be randomly assigned to receive one of several nonsteroidal anti-inflammatory drugs (NSAIDs) with differing chemical properties (e.g., diclofenac, meloxicam, or indomethacin), in combination with a home-based exercise program for shoulder adhesive capsulitis. Patients' sociodemographic data, as well as detailed clinical and examination findings and baseline outcomes, will be recorded. Patients will be informed about their condition, and modifications to activities of daily living will be recommended.Patients' pain phenotypes (nociceptive, neuropathic, nociplastic) will be categorized based on clinical history and questionnaires, and it will be determined which pain types derive greater benefit from NSAIDs.\n\nFollow-up assessments will be conducted at the end of the first and second weeks. At the first-week follow-up, pain intensity will be evaluated using the Visual Analog Scale (VAS). If the treatment is deemed effective (defined as a ≥3-point reduction or ≥50% decrease in VAS), the same NSAID will be continued for an additional week; otherwise, it will be switched to an alternative NSAID with a different biochemical profile (group). The outcomes assessments will be performed by a blinded evaluator to minimize bias.",[27,28,29,65,30,31],"NSAID (Non-Steroidal Anti-Inflammatory Drug)",[67,68,69,38,39,70],"frozen shoulder","adhesive capsulitis","shoulder pain","Nonsteroidal Anti-Inflammatory Drugs",{"date":43,"type":44},{"date":46,"type":44},{"date":74,"type":21},"2027-03-30",{"name":50,"class":51},{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":84,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":52},"100632215","impact-of-low-back-pain-phenotypes-on-function-and-quality-of-life-in-ankylosing-spondylitis-100632215","NCT07510789","Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis","The Impact of Low Back Pain Phenotypes on Pain Intensity, Functional Status, and Quality of Life in Patients With Ankylosing Spondylitis","Backpaın","Inclusion Criteria:\n\n* Being over 18 years of age Voluntary participation in the study Having been diagnosed with ankylosing spondylitis\n\nExclusion Criteria:\n\n* Those under 18 years of age\n\n  * Those with major psychiatric illnesses\n  * Those with communication problems\n  * Other causes of back pain",{"count":85,"type":21},200,"OBSERVATIONAL","This study aims to better understand different types of low back pain in patients with ankylosing spondylitis. Low back pain is a common problem in these patients and may affect daily activities and quality of life.\n\nA total of 200 patients with ankylosing spondylitis who have had low back pain for at least three months will be included in the study. Participants will be evaluated during a single visit.\n\nThe study will assess pain severity, physical function, and quality of life using standard questionnaires. It will also examine how different pain types are related to these outcomes.\n\nThe results of this study may help improve the understanding of pain in ankylosing spondylitis and support better patient management.",[89,90],"Ankylosing Spondylitis","Low Back Pain",[92,93,94],"ankylosing spondylitis","types of paın","lower back pain","2026-03-30",{"date":97,"type":44},"2026-04-03",{"date":99,"type":44},"2025-12-01",{"date":101,"type":21},"2026-12-01",{"name":50,"class":51},{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":107,"acronym":4,"eligibilityCriteria":108,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":109,"enrollmentInfo":110,"targetDuration":4,"studyType":22,"phases":112,"briefSummary":113,"conditions":114,"keywords":116,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":123,"startDateStruct":125,"completionDateStruct":126,"leadSponsor":127,"locationsCount":52},"100632032","comparison-of-the-eficacy-of-mulligan-mobilization-and-myofascial-release-in-patients-with-cervicogenic-headache-100632032","NCT07508410","Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache","Inclusion criteria:\n\n* Individuals aged 18-65\n* Having experienced neck or headache for 3 months\n* Meeting the diagnostic criteria for cervicogenic headache;\n\n  * Unilateral pain\n  * Reduced range of motion in the neck\n  * Ipsilateral shoulder discomfort\n  * Ipsilateral arm discomfort\n  * Pain that worsens with different neck movements and is painful on palpation\n\nExclusion criteria:\n\n* Migraine\n* Cluster headache\n* Cervical radiculopathy\n* Entrapment neuropathy\n* Myelopathy\n* Rheumatoid arthritis\n* Undergoing cervical spinal surgery\n* Pregnant women\n* Those who received physical therapy within 6 months\n* Those with a history of major psychiatric illness\n* Those with a history of uncontrolled systemic diseases (cardiovascular, pulmonary, hepatic, renal, hematological)\n* Those with a history of uncontrolled systemic endocrine diseases (dm, hyperthyroidism)","65 Years",{"count":111,"type":21},90,[24],"Cervicogenic headache (CBH) is defined as a headache caused by a disorder in the cervical spine, bones, discs, or soft tissue elements, which is also accompanied by neck pain.\n\nUnilateral, non-reversible oculo, fronto, temporal pain, pain that increases with poor neck positioning and incorrect neck movements, and may be seen with restricted movement in the upper cervical and occiput regions.\n\nThe aim of this thesis is to compare the effectiveness of Mulligan mobilization technique and myofascial release methods used in the treatment of cervicogenic headache through a prospective clinical study.",[115],"Cervicogenic Headache",[117,118,119,120,121,122],"Neck pain","Massage therapy","Musculoskeletal diseases","Musculoskeletal manipulation","Rehabilitation","Complementary therapies",{"date":124,"type":44},"2026-04-02",{"date":99,"type":44},{"date":101,"type":21},{"name":50,"class":51},{"id":129,"slug":130,"hasResults":11,"nctId":131,"briefTitle":132,"officialTitle":133,"acronym":4,"eligibilityCriteria":134,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":135,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":137,"conditions":138,"keywords":147,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":150,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":52},"100613051","adherence-to-home-based-exercises-in-musculoskeletal-disorders-100613051","NCT07261553","Adherence to Home-Based Exercises in Musculoskeletal Disorders","Adherence to Home-Based Exercise Programs Among Patients With Musculoskeletal Disorders and Its Influencing Factors","Inclusion criteria:\n\n* Be 18 years of age or older\n* To have a musculoskeletal disease (degenerative, neurological or orthopedic)\n* To be given a home exercise program\n* To have cognitive and language functions to communicate, to be a volunteer\n\nExclusion criteria:\n\n* Those with major psychiatric illness\n* Those with cognitive dysfunction\n* Those with communication disorders, reluctant\u002Freluctant to participate\n* Those with any condition other than a primary degenerative, orthopedic, or neurological disease that could significantly affect exercise adherence, including musculoskeletal or systemic disorders (e.g., severe anemia, heart failure, respiratory failure, uncontrolled diabetes, inflammatory rheumatic disease, recent fractures, or active infections).",{"count":136,"type":21},252,"Home exercise program is recommended by physicians to patients and their relatives to do at home and It is a treatment option in which the physician describes how to do it. Home workout program to be completed at home to complement and reinforce their program in the clinic It is a personalized set of therapeutic exercises that are taught. There are factors that can change exercise compliance; There are some reasons why some patients adhere to the prescribed home exercise program and others do not.\n\nAdherence to home exercises is a major issue in rehabilitation and the reasons for this are multifactorial; It includes both psychological and specific conditions factors that vary between each individual and these conditions should be taken into account by clinicians in designing personalized exercise programs.\n\nHome exercise programs constitute a fundamental component of rehabilitation and are widely prescribed by physicians support therapeutic gains beyond the clinical environment. These individualized programs aim to maintain functional improvements, reduce symptoms, and promote self-management among individuals with musculoskeletal disorders. Although adherence to home-based exercises is recognized as a key determinant of rehabilitation outcomes, non-adherence remains a persistent challenge. Despite growing emphasis on the importance of exercise compliance, the existing literature provides relatively limited and insufficient evidence regarding the factors that influence adherence across different musculoskeletal conditions, including degenerative, orthopedic, and neurological disorders.\n\nAddressing this gap, the present prospective longitudinal cohort study aims to evaluate adherence to individualized home-based exercise programs among patients with diverse musculoskeletal conditions and to determine whether adherence behaviors differ across diagnostic groups. In addition, the study seeks to identify demographic, clinical, psychosocial, and functional factors associated with exercise compliance. By integrating structured clinical evaluations with validated outcome measures, this study aims not only to clarify the determinants of exercise adherence but also to contribute to the development of more effective, condition-specific strategies to enhance sustained engagement in home-based rehabilitation.",[139,140,141,142,143,34,144,145,146],"Exercise Training","Adherence, Treatment","Musculoskeletal Disease","Rehabilitation Exercise","Adherence, Patient","Stroke","Orthopedic Operations","Degeneration of Spine and Osteoarticular",[34,148,142,141,143],"adherence","2026-03-21",{"date":151,"type":44},"2026-03-25",{"date":153,"type":44},"2024-12-30",{"date":155,"type":21},"2026-05-15",{"name":50,"class":51},{"id":158,"slug":159,"hasResults":11,"nctId":160,"briefTitle":161,"officialTitle":162,"acronym":4,"eligibilityCriteria":163,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":109,"enrollmentInfo":164,"targetDuration":4,"studyType":22,"phases":166,"briefSummary":167,"conditions":168,"keywords":174,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":178,"startDateStruct":180,"completionDateStruct":182,"leadSponsor":184,"locationsCount":52},"100592600","splinting-vs-exercise-in-de-quervains-tenosynovitis-100592600","NCT06995534","Splinting vs Exercise in De Quervain's Tenosynovitis","Comparison of Static Hand-Wrist Splinting and Exercise Therapy in the Management of De Quervain's Tenosynovitis","Inclusion Criteria:\n\n* Adults aged between 18 and 65 years\n\nPatients experiencing wrist pain and tenderness for less than 3 months and clinically diagnosed with acute or subacute De Quervain's tenosynovitis\n\nVisual Analog Scale (VAS) pain score ≥ 3\n\nExclusion Criteria:\n\n* History of trauma\n\nWrist fractures\n\nLocal infection\n\nPresence of rheumatologic diseases (e.g., rheumatoid arthritis, psoriatic arthritis)\n\nPresence of symptomatic hand osteoarthritis\n\nContinuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids\n\nReceipt of physical therapy for the hand or wrist within the past 3 months\n\nCorticosteroid injection into the hand or wrist within the past 3 months\n\nDiagnosed with significant neurological disorders (e.g., upper motor neuron disease)\n\nPresence of uncontrolled systemic diseases (e.g., uncontrolled diabetes mellitus, congestive heart failure, chronic kidney disease, hepatic failure)\n\nMajor psychiatric disorders\n\nCommunication difficulties",{"count":165,"type":21},40,[24],"De Quervain's disease is a painful tenosynovitis of the abductor pollicis longus and extensor pollicis brevis muscle tendons located in the first dorsal compartment. The primary treatment for De Quervain's disease is conservative; surgical intervention is rarely required. Currently, there is no standardized treatment protocol supported by strong, up-to-date evidence.\n\nThe aim of this study is to compare the effectiveness of a static hand-wrist resting splint and exercise therapy in the conservative treatment of De Quervain's tenosynovitis. Patients will be evaluated in terms of pain levels, functional\u002Fsymptom status, hand-finger strength, pressure pain threshold (PPT), tendon cross-sectional area measured by ultrasound, and the presence of effusion findings (semiquantitative; 0-3), and patient satisfaction.",[169,170,171,172,173],"Splints","Exercise Therapy","De Quervains Tenosynovitis","Pain Management","Ultrasonographic",[175,171,176,177,173],"pain","exercise therapy","splints",{"date":179,"type":44},"2026-03-24",{"date":181,"type":44},"2025-05-29",{"date":183,"type":21},"2026-04-30",{"name":50,"class":51},{"id":186,"slug":187,"hasResults":11,"nctId":188,"briefTitle":189,"officialTitle":190,"acronym":4,"eligibilityCriteria":191,"healthyVolunteers":11,"sex":16,"minAge":192,"maxAge":193,"enrollmentInfo":194,"targetDuration":4,"studyType":22,"phases":195,"briefSummary":196,"conditions":197,"keywords":202,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":207,"lastUpdatePostDateStruct":208,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":213,"locationsCount":52},"100591199","effectiveness-of-kinesiotaping-and-peloidotherapy-in-carpal-tunnel-syndrome-100591199","NCT06977321","Effectiveness of Kinesiotaping and Peloidotherapy in Carpal Tunnel Syndrome","A Comparative Evaluation of the Effectiveness of Kinesiotaping and Peloidotherapy in Patients With Idiopathic Carpal Tunnel Syndrome","Inclusion Criteria:\n\n* Being between the ages of 18-65\n* Agreeing to participate voluntarily in the study\n* Being diagnosed with mild or moderate idiopathic chronic CTS as a result of anamnesis, clinical examination and nerve conduction study\n\nExclusion Criteria:\n\n* Presence of predisposing etiological factors for CTS such as diabetes mellitus, chronic kidney and liver disease, acromegaly, rheumatological diseases, acute trauma, hypothyroidism, etc.\n* Being diagnosed with severe CTS\n* Having a history of previous wrist surgery or trauma\n* Having atrophy in the thenar region or weakness in the thenar muscles\n* Having cervical radiculopathy, thoracic outlet syndrome, polyneuropathy, brachial neuropathy or proximal median nerve neuropathy\n* Having had steroid injections in the last 3 months and taking oral steroid medications\n* Being pregnant\n* Having an open wound or rash in the wrist and its surroundings that would prevent treatment\n* Patients who are receiving or will receive another\u002Fadditional treatment for CTS\n* Patients with a bifid median nerve, persistent median artery, ganglion cyst, tenosynovitis, or tendinitis in the wrist.","18 Months","65 Months",{"count":111,"type":21},[24],"Patients diagnosed with mild and moderate idiopathic CTS will be randomly divided into three groups. Patients who received 15 sessions of peloid therapy along with a home exercise program will constitute the first group. The second group will consist of patients who received a total of 6 sessions of kinesiotaping twice a week along with a home exercise program. Patients who were given only a home exercise program will be included in the third group. \"Patients will be evaluated in detail in terms of clinical examination and outcomes three weeks after the end of treatment and again at three months.",[198,199,200,172,201],"Carpal Tunnel Syndrome (CTS)","Kinesio Taping","Exercise","Peloidotherapy",[203,201,204,175,205,206],"carpal tunnel syndrome (CTS)","exercise","kinesio taping","ultrasound","2026-03-19",{"date":209,"type":44},"2026-03-20",{"date":211,"type":44},"2025-05-17",{"date":155,"type":21},{"name":50,"class":51},{"id":215,"slug":216,"hasResults":11,"nctId":217,"briefTitle":218,"officialTitle":218,"acronym":219,"eligibilityCriteria":220,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":221,"targetDuration":222,"studyType":86,"phases":4,"briefSummary":223,"conditions":224,"keywords":227,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":230,"lastUpdatePostDateStruct":231,"startDateStruct":233,"completionDateStruct":234,"leadSponsor":235,"locationsCount":52},"100630535","effects-of-low-back-pain-types-on-pain-severity-and-quality-of-life-in-patients-with-failed-back-surgery-syndrome-100630535","NCT07488936","Effects of Low Back Pain Types on Pain Severity and Quality of Life in Patients With Failed Back Surgery Syndrome","back pain","Inclusion Criteria:\n\n* \\*Being over 18 years of age\n\n  * Being willing to participate in the study\n  * Having been diagnosed with failed back surgery syndrome\n\nExclusion Criteria:\n\n* \\*Those under 18 years of age\n\n  * Those with major psychiatric illnesses\n  * Those with communication problems\n  * Other causes of back pain",{"count":85,"type":21},"1 Year","The aim of this study is to determine the effects of different types of low back pain on pain intensity and quality of life in patients with failed low back surgery syndrome.\n\nThe study will include 200 patients with failed lumbar spine surgery syndrome who present to the physical therapy and rehabilitation (FTR) outpatient clinics of Konya Beyhekim Training and Research Hospital with complaints of lower back pain lasting at least 3 months.\n\nPatients will be evaluated in a single session. The Visual Analog Scale (VAS), Pain Catastrophizing Scale (PCS) will be used to determine the patients' pain level and impact, the Roland-Morris Disability Questionnaire (RMDQ) will be used for functionality assessment, and the SF-36 score will be used for quality of life assessment.\n\nTo determine the type of pain:\n\nThose with pain levels above the cutoff value on the DN4 (Douleur Neuropathique 4 Questions) pain scale will be diagnosed with neuropathic pain.\n\nFor nociplastic pain affecting the musculoskeletal system, a diagnosis of nociplastic pain will be made according to clinical criteria and grading scores.\n\nThose who do not meet these criteria will be classified as having nociceptive pain.",[225,226],"Failed Back Surgery Syndrome","Chronic Pain",[228,219,229],"failed back surgery syndrome","types of pain","2026-03-18",{"date":232,"type":44},"2026-03-23",{"date":99,"type":44},{"date":101,"type":21},{"name":50,"class":51},{"id":237,"slug":238,"hasResults":11,"nctId":239,"briefTitle":240,"officialTitle":241,"acronym":4,"eligibilityCriteria":242,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":243,"targetDuration":4,"studyType":22,"phases":245,"briefSummary":246,"conditions":247,"keywords":253,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":259,"lastUpdatePostDateStruct":260,"startDateStruct":261,"completionDateStruct":263,"leadSponsor":265,"locationsCount":52},"100612664","comparative-evaluation-of-finger-splint-paraffin-and-peloidotherapy-interventions-in-the-management-of-trigger-finger-100612664","NCT07256522","Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger","Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger. A Prospective, Randomized, Controlled Study","Inclusion Criteria:\n\n* Being between 18 and 75 years of age and willing to participate in the study\n* Having a diagnosis of idiopathic single trigger finger, Grade 2-3\n\nExclusion Criteria:\n\n* Patients with triggering in more than one finger\n* Patients with triggering at the A3 pulley or with Grade 1 or Grade 4 trigger finger\n* Patients with thumb (pollex) trigger finger\n* Patients who have undergone any injection or interventional procedure (release surgery) for trigger finger within the past 6 months\n* Patients who have received physical therapy for the hand within the past 6 months\n* Patients currently using corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs)\n* Patients with inflammatory or autoimmune rheumatologic diseases such as rheumatoid arthritis, systemic lupus erythematosus, gout, or psoriatic arthritis\n* Patients with other musculoskeletal disorders (e.g., carpal tunnel syndrome, de Quervain's tenosynovitis, symptomatic hand osteoarthritis, or Dupuytren's contracture) or neurological diseases (e.g., stroke-related hemiparesis, spinal cord injury, brachial plexus injury, multiple sclerosis, or Parkinsonism) affecting the same hand\n* Patients with musculoskeletal disorders causing pain and\u002For limitation in the proximal upper extremity on the affected side (e.g., periarthritis, lateral epicondylitis, mononeuropathy, or radiculopathy)\n* Patients with significant metabolic diseases (e.g., hypothyroidism, Cushing's syndrome, or uncontrolled diabetes)\n* Patients with any condition that may interfere with treatment, such as open wounds, rashes, local infections, or active malignant disease of the hand\n* Patients with a history of hand trauma (chronic or repetitive)\n* Patients unwilling to complete the self-assessment questionnaires either independently or with assistance\n* Pregnant women",{"count":244,"type":21},60,[24],"Patients aged 18-75 years who present with trigger finger to a tertiary rehabilitation hospital and agree to participate will be included in the study. Participants will be randomly allocated into three groups using block randomization. The first group will use a static finger splint that blocks the proximal interphalangeal joint for 6 weeks, along with a home exercise program. The second group will receive paraffin bath therapy, and the third group will receive peloidotherapy, both in combination with home exercises.\n\nAll patients will receive education about the disease and activity modification. The finger joint-restricting splint and exercises will be applied for 6 weeks. Evaluations will be conducted at baseline, at the end of the 3rd week, and at the end of the 6th week by a blinded assessor. No analgesic or anti-inflammatory medication will be permitted during the study, and patients will be instructed to avoid using analgesics within 24 hours prior to each assessment.",[248,249,250,201,251,252],"Trigger Finger","Splint Therapy","Paraffin Bath","Efficacy and Safety","Randomised Clinical Trial",[254,255,256,257,258],"trigger finger","splint therapy","paraffin bath","peloidotherapy","Randomised Controlled Study","2026-03-17",{"date":207,"type":44},{"date":262,"type":44},"2025-12-15",{"date":264,"type":21},"2027-02-15",{"name":50,"class":51},{"id":267,"slug":268,"hasResults":11,"nctId":269,"briefTitle":270,"officialTitle":271,"acronym":4,"eligibilityCriteria":272,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":273,"targetDuration":4,"studyType":22,"phases":275,"briefSummary":276,"conditions":277,"keywords":282,"overallStatus":287,"whyStopped":4,"lastUpdateSubmitDate":288,"lastUpdatePostDateStruct":289,"startDateStruct":291,"completionDateStruct":292,"leadSponsor":294,"locationsCount":4},"100617889","postoperative-analgesic-efficacy-between-adductor-canal-block--ipack-block-and-adductor-canal-block--genicular-nerve-block-in-total-knee-arthroplasty-100617889","NCT07324486","Postoperative Analgesic Efficacy Between Adductor Canal Block + IPACK Block and Adductor Canal Block + Genicular Nerve Block in Total Knee Arthroplasty","Comparison of Functional Outcomes and Postoperative Analgesic Efficacy Between Adductor Canal Block + IPACK Block and Adductor Canal Block + Genicular Nerve Block in Patients Undergoing Total Knee Arthroplasty","Inclusion Criteria:\n\n1. Patients scheduled for spinal anesthesia with TDA.\n2. Age ≥18.\n3. American Society of Anesthesiologists (ASA) physical status score I-III.\n4. Patients capable of providing informed consent.\n\nExclusion Criteria:\n\n1. Active infection at the injection site.\n2. Coagulopathy or systemic sepsis.\n3. Severe hypovolemia.\n4. Patients who refuse regional anesthesia.\n5. Known allergy to local anesthetics.\n6. Cognitive impairment or uncooperative patients.",{"count":274,"type":21},50,[24],"The aim of this study is to compare the postoperative analgesic efficacy and functional outcomes of the IPACK+Adductor Canal Block with the Genicular Nerve Block+Adductor Canal Block block in patients undergoing total knee arthroplasty (TKA). The primary objective (measurable) is to evaluate functional improvement using 6-Clicks scores, while secondary objectives include pain scores (Vas Score), opioid consumption, hospital stay duration, and patient satisfaction (Patient Satisfaction Index).\n\nIPACK : The infiltration between the popliteal artery and capsule of the knee",[278,279,280,281],"Total Knee Arthroplasty","Adductor Canal Block","Genicular Nerves Block","IPACK Block Multimodal Analgesia",[283,284,285,286],"total knee arthroplasty","adductor canal block","genicular nerves block","IPACK","NOT_YET_RECRUITING","2025-12-30",{"date":290,"type":44},"2026-01-07",{"date":262,"type":21},{"date":293,"type":21},"2026-02-01",{"name":50,"class":51},{"id":296,"slug":297,"hasResults":11,"nctId":298,"briefTitle":299,"officialTitle":300,"acronym":4,"eligibilityCriteria":301,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":109,"enrollmentInfo":302,"targetDuration":304,"studyType":86,"phases":4,"briefSummary":305,"conditions":306,"keywords":308,"overallStatus":287,"whyStopped":4,"lastUpdateSubmitDate":313,"lastUpdatePostDateStruct":314,"startDateStruct":316,"completionDateStruct":317,"leadSponsor":318,"locationsCount":52},"100616286","effects-of-the-4-7-8-breathing-technique-on-postoperative-pain-scores-anxiety-and-sleep-quality-in-patients-100616286","NCT07303634","Effects of the 4-7-8 Breathing Technique on Postoperative Pain Scores, Anxiety, and Sleep Quality in Patients","Effects of the 4-7-8 Breathing Technique, One of the Deep Breathing Techniques, on Postoperative Pain Scores, Anxiety, and Sleep Quality in Patients Undergoing Laparoscopic Cholecystectomy","Inclusion Criteria:\n\n1. Participants must be informed and give voluntary consent to participate in the study.\n2. Patients who have undergone laparoscopic cholecystectomy.\n3. Patients with an ASA physical performance score of 1-3.\n4. Patients aged 18-65 years.\n\nExclusion Criteria:\n\n1. Patients who do not wish to continue participating in the study\n2. Patients whose medical condition has deteriorated.\n3. Those with a history of medication use accompanied by depression and other psychiatric diagnoses\n4. Those with a history of substance dependence\n5. Those with respiratory tract infection or pathology (Asthma, COPD)\n6. Those with neuromuscular disorders\n7. Those under the age of 18\n8. Patients who cannot read or write Turkish or who are uncooperative\n9. Those unable to adapt to breathing training techniques\n10. Conversion from laparoscopic surgery to laparotomy",{"count":303,"type":21},100,"1 Day","This study aims to evaluate the effects of teaching the 4-7-8 breathing technique, one of the deep breathing techniques, to patients undergoing laparoscopic cholecystectomy surgery and applying it during the preoperative and postoperative periods on postoperative pain levels, anxiety levels, and sleep quality. Secondary objectives are to evaluate patients' postoperative peripheral oxygen saturation and length of hospital stay.\n\nPatients will be randomized into two groups using a closed opaque envelope technique, and the groups will be determined. This procedure will be performed by a researcher not involved in the study. Patients undergoing Laparoscopic Cholecystectomy will be randomized. The groups will be coded as A and B. Group A patients will be instructed to practice the 4-7-8 breathing technique for 6 hours per day, 10 cycles per hour, during the preoperative and postoperative periods after receiving training. Group B will be the control group, and routine follow-ups will be performed on these patients. Participants' correct and regular application of the breathing technique will be verified through a short test after training and follow-up calls. Participants will be given an \"Informed Consent Form,\" and their consent will also be obtained not to interact with each other or share group information. The perioperative process will be monitored by anesthesiologists not involved in the study.",[307],"Laparoscopic Cholecystectomy Surgery",[309,310,311,312],"laparoscopic cholecystectomy","respiratory physiotherapy","visual analog scale","The Richards-Campbell Sleep Questionnaire","2025-12-18",{"date":315,"type":44},"2025-12-26",{"date":262,"type":21},{"date":293,"type":21},{"name":50,"class":51},{"id":320,"slug":321,"hasResults":11,"nctId":322,"briefTitle":323,"officialTitle":324,"acronym":4,"eligibilityCriteria":325,"healthyVolunteers":326,"sex":16,"minAge":327,"maxAge":4,"enrollmentInfo":328,"targetDuration":304,"studyType":86,"phases":4,"briefSummary":329,"conditions":330,"keywords":334,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":339,"lastUpdatePostDateStruct":340,"startDateStruct":342,"completionDateStruct":344,"leadSponsor":346,"locationsCount":52},"100584444","rheumatoid-arthritis-and-osteosarcopenia-associated-factors-100584444","NCT06889415","Rheumatoid Arthritis and Osteosarcopenia: Associated Factors","The Frequency of Osteosarcopenia in Patients With Rheumatoid Arthritis and the Factors Affecting the Sarcopenia-osteoporosis Relationship","Inclusion criteria:\n\n1. Being diagnosed with RA according to the ACR\u002FEULAR 2010 criteria\n2. Being a female or male over the age of 50\n3. Having the mental and physical capacity to complete the study questionnaires and tests\n4. Providing voluntary consent to participate in the study by signing the Informed Consent Form\n\nExclusion Criteria:\n\n1. Having an acute illness\u002Fdisability or significant cognitive impairment that prevents understanding and performing the required tests\n2. Having thyroid or parathyroid disease, uncontrolled diabetes, Cushing's syndrome, anemia.\n3. History of malignancy\n4. Severe cardiovascular disease, enal failure, advanced-stage COPD, decompensated liver disease\n5. History of gastrointestinal (GIS) surgery\n\n7-Having another coexisting autoimmune\u002Finflammatory rheumatic disease (e.g., SLE, Ankylosing Spondylitis, etc.), psoriatic arthritis, vasculitis, familial Mediterranean fever...)\n\n8-Having severe\u002Fsymptomatic hand osteoarthritis and\u002For deformities\n\n9-Severe\u002Fsymptomatic osteoarthritis in the knee, lumbar, hip, or ankle region\n\n10-Having Carpal Tunnel Syndrome, De Quervain, lateral epicondylitis, cubital tunnel syndrome or a history of traumatic hand injury\n\n11-Having a significant neurological disease, stroke, MS, myopathy, Parkinson's disease, radiculopathy\u002Fpolyneuropathy\u002Fbrachial plexopathy or others nerve root compressions\n\n12-History of surgical intervention on the upper and lower extremities or spine\n\n13-Having severe kyphosis or scoliosis\n\n14-Having any others disease causing balance disorders (neurological, orthopedic, metabolic, etc.)\n\n15-Having a major\u002Fsignificant psychiatric disorder (based on the medical history, and hospital records)\n\n16-Current use of androgens or estrogens\n\n17-Having prostheses, being fully dependent, or immobilized",true,"50 Years",{"count":85,"type":21},"Our study is a cross-sectional study, and its aim is to compare and analyze the prevalence of sarcopenia and osteoporosis in patients with rheumatoid arthritis (RA) with a control group and to reveal the impact of sarcopenia on osteoporosis, fall risk, and fracture risk. This prospective cross-sectional study will include 100 rheumatoid arthritis patients and 100 healthy controls, matched for age and sex. Patients will be consecutively and meticulously enrolled based on inclusion and exclusion criteria.\n\nA detailed medical history and examination will be performed on the patients, and their clinical and sociodemographic characteristics will be recorded. Blood tests for RA (RF, Anti-Cyclic Citrullinated Peptide (anti-CCP), CRP, ESR) and disease activity levels (DAS28) will be recorded. The prevalence of osteosarcopenia will be assessed in both the RA and healthy control groups.These groups will be evaluated using various scales and tests (including power, performance tests) including musculoskeletal ultrasonographic measurements and clinical functional assessment tests. he sarcopenic group will be categorized based on the level of sarcopenia, according to the new ISarcoPRM criteria (non-sarcopenic, dynapenic, sarcopenic, and severe sarcopenic). Osteosarcopenia will be evaluated for both groups, and the collected data will be analyzed with primary and secondary outcomes. The analysis will explore the potential relationships between rheumatoid inflammation, sarcopenia, and osteoporosis.",[331,332,333],"Osteosarcopenia","Rheumatoid Arthritis (RA)","Sarcopenia",[335,336,337,338],"osteosarcopenia","sarcopenia","Ultrasonography","rheumatoid arthritis","2025-07-05",{"date":341,"type":44},"2025-07-10",{"date":343,"type":44},"2023-08-15",{"date":345,"type":21},"2025-11-30",{"name":50,"class":51},{"id":348,"slug":349,"hasResults":11,"nctId":350,"briefTitle":351,"officialTitle":351,"acronym":4,"eligibilityCriteria":352,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":109,"enrollmentInfo":353,"targetDuration":4,"studyType":22,"phases":355,"briefSummary":356,"conditions":357,"keywords":359,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":363,"lastUpdatePostDateStruct":364,"startDateStruct":366,"completionDateStruct":368,"leadSponsor":369,"locationsCount":52},"100590328","comparison-of-the-effectiveness-of-mulligan-mobilization-and-myofascial-release-technique-in-patients-with-lateral-epicondylitis-100590328","NCT06965985","Comparison of the Effectiveness of Mulligan Mobilization and Myofascial Release Technique in Patients With Lateral Epicondylitis","Inclusion Criteria:\n\nAged between 18 and 65 years\n\nDiagnosed with unilateral lateral epicondylitis (LE)\n\nExclusion Criteria:\n\nYounger than 18 or older than 65 years\n\nCommunication difficulties\n\nHistory of injection, surgery, or physical therapy in the elbow region within the past 6 months\n\nPain originating from the cervical spine (e.g., radiculopathy, spinal stenosis), shoulder problems, or other elbow pathologies unrelated to LE\n\nHistory of elbow osteoarthritis or previous elbow fracture\n\nHistory of polyneuropathy\n\nUncontrolled systemic diseases (e.g., cardiovascular, pulmonary, hepatic, renal, hematologic disorders)\n\nUncontrolled systemic endocrine disorders (e.g., diabetes mellitus, hyperthyroidism)\n\nHistory of major psychiatric disorders\n\nHistory of rheumatic diseases such as fibromyalgia, polymyalgia rheumatica, ankylosing spondylitis, or rheumatoid arthritis\n\nPresence of bleeding disorders or use of anticoagulant medications\n\nNeurological deficits\n\nPosterior interosseous nerve (PIN) syndrome\n\nCurrent or past use of wrist resting splints or elbow braces",{"count":354,"type":21},114,[24],"Lateral epicondylitis (LE), recognized as one of the most prevalent causes of elbow pain, has an estimated incidence ranging from 1% to 3%. It most commonly presents in individuals between the ages of 40 and 50 and tends to affect the dominant limb more frequently. In the adult population, LE is the leading cause of lateral elbow pain.\n\nTo date, more than 40 different treatment modalities have been described for the management of LE, primarily aiming to alleviate pain and enhance functional outcomes.\n\nHowever, a universally accepted standard treatment has yet to be established. The objective of this thesis is to compare the clinical effectiveness of the Mulligan mobilization technique and the myofascial release technique-both commonly utilized in the treatment of LE-through a prospective clinical study.",[358],"Lateral Epicondylitis (Tennis Elbow)",[360,361,362,170],"Lateral Epicondylitis","Mobilization Techniques","Myofascial Release","2025-05-02",{"date":365,"type":44},"2025-05-11",{"date":367,"type":44},"2025-01-01",{"date":46,"type":21},{"name":50,"class":51},{"id":371,"slug":372,"hasResults":11,"nctId":373,"briefTitle":374,"officialTitle":375,"acronym":4,"eligibilityCriteria":376,"healthyVolunteers":11,"sex":377,"minAge":17,"maxAge":109,"enrollmentInfo":378,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":379,"conditions":380,"keywords":4,"overallStatus":287,"whyStopped":4,"lastUpdateSubmitDate":382,"lastUpdatePostDateStruct":383,"startDateStruct":385,"completionDateStruct":386,"leadSponsor":388,"locationsCount":4},"100573070","fibromyalgia-exercise-adherence-and-barriers-100573070","NCT06741488","Fibromyalgia, Exercise Adherence and Barriers","Adherence of Women With Fibromyalgia to Home Exercise Programme and Perceived Barriers to Exercise","Inclusion Criteria:\n\n* Being diagnosed with fibromyalgia according to ACR 2016 criteria\n* Female\n* To be informed about the benefits of exercise, the importance of exercise compliance and to be shown the exercise program in practice and to be given a printed form\n\nExclusion Criteria:\n\n* Having a systemic or mental disease that may prevent exercise","FEMALE",{"count":303,"type":21},"We aimed to investigate adherence to exercise and perceived barriers to exercise in patients with fibromyalgia who were advised to exercise.",[381],"Fibromyalgia","2024-12-18",{"date":384,"type":44},"2024-12-19",{"date":367,"type":21},{"date":387,"type":21},"2025-07-01",{"name":50,"class":51},""]